Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-15 Sale | 2025-05-19 5:33 pm | OnKure Therapeutics Inc. | OKUR | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Cormorant Private Healthcare Fund V LP Chen Bihua Former 10% Owner | 1,813,439 | $1.8545 | $3,363,023 | 0 (Indirect) | View |
| 2025-05-15 Purchase | 2025-05-19 4:43 pm | OnKure Therapeutics Inc. | OKUR | ACORN BIOVENTURES L.P. ACORN CAPITAL ADVISORS GP LLC Hove Anders D 10% Owner | 1,400,000 | $1.85 | $2,590,000 | 2,839,674 (Indirect Direct) | View |
| 2025-05-12 Sale | 2025-05-14 4:36 pm | OnKure Therapeutics Inc. | OKUR | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Cormorant Private Healthcare Fund V LP Chen Bihua 10% Owner | 24,300 | $1.985 | $48,236 | 1,813,439 (Indirect) | View |
| 2025-04-04 Sale | 2025-04-08 5:32 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 874 | $2.94 | $2,570 | 3,682 (Direct) | View |
| 2025-04-04 Sale | 2025-04-08 5:30 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 3,122 | $2.9398 | $9,178 | 13,209 (Direct) | View |
| 2024-09-24 Purchase | 2024-09-26 09:33 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 98,346 | $1.4717 | $144,738 | 4,478,164 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-28 Option Award | 2025-05-30 5:05 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 4:54 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 4:53 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 4:52 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 4:51 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 4:50 pm | N/A 2035-05-27 | OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director | 7,650 | $0 | 7,650 (Direct) | View |
Ownership | 2025-05-27 7:44 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | ACORN BIOVENTURES 2 L.P. Acorn Capital Advisors GP 2 LLC 10% Owner | 0 | $0 | 1,129,730 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 4:48 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 2,580 | $0 | 2,580 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 4:37 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 3,469 | $0 | 3,469 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 8:36 pm | N/A 2035-01-26 | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 8:35 pm | N/A 2035-01-26 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 8:33 pm | N/A 2035-01-26 | OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 8:33 pm | N/A 2035-01-26 | OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2024-10-15 4:08 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Cormorant Private Healthcare Fund V LP Chen Bihua 10% Owner | 0 | $0 | 1,837,739 (Indirect) | View |
Ownership | 2024-10-09 4:15 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | ACORN BIOVENTURES L.P. ACORN CAPITAL ADVISORS GP LLC Hove Anders D 10% Owner | 0 | $0 | 1,439,674 (Direct) | View |
| 2024-10-07 Other | 2024-10-09 11:25 am | N/A N/A | OnKure Therapeutics Inc. | OKUR | Leonard Braden Michael Former 10% owner of RPHM | 447,815 | $0 | 895,630 (Indirect) | View |
| 2024-10-04 Option Award | 2024-10-08 7:29 pm | N/A 2032-01-10 | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 575,979 | $0 | 575,979 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:28 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:27 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:27 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:26 pm | N/A 2032-01-10 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 158,045 | $0 | 158,045 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:25 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:24 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer | 137,603 | $0 | 137,603 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:23 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:21 pm | N/A 2031-07-06 | OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director | 23,323 | $0 | 23,323 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:20 pm | N/A 2034-02-05 | OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer | 149,984 | $0 | 149,984 (Direct) | View |